215 related articles for article (PubMed ID: 17540676)
1. Rapid decrease in the prevalence of macrolide-resistant group A streptococci due to the appearance of two epidemic clones in Cantabria (Spain).
Oliver MA; García-Delafuente C; Cano ME; Pérez-Hernández F; Martínez-Martínez L; Albertí S
J Antimicrob Chemother; 2007 Aug; 60(2):450-2. PubMed ID: 17540676
[No Abstract] [Full Text] [Related]
2. Antimicrobial susceptibility patterns and macrolide resistance genes of beta-hemolytic streptococci in Korea.
Uh Y; Jang IH; Hwang GY; Lee MK; Yoon KJ; Kim HY
Antimicrob Agents Chemother; 2004 Jul; 48(7):2716-8. PubMed ID: 15215133
[TBL] [Abstract][Full Text] [Related]
3. Macrolide-resistant Streptococcus pyogenes in Central Greece: prevalence; mechanism and molecular identification.
Malli E; Tatsidou E; Damani A; Pantelidi K; Petinaki E; Skoulakis C; Drougka E; Spiliopoulou I
Int J Antimicrob Agents; 2010 Jun; 35(6):614-5. PubMed ID: 20206477
[No Abstract] [Full Text] [Related]
4. Decrease of erythromycin resistance in group A streptococci by change of emm distribution.
Koh EH; Kim S; Lee NY
Jpn J Infect Dis; 2008 Jul; 61(4):261-3. PubMed ID: 18653965
[TBL] [Abstract][Full Text] [Related]
5. Distribution of subclasses mefA and mefE of the mefA gene among clinical isolates of macrolide-resistant (M-phenotype) Streptococcus pneumoniae, viridans group streptococci, and Streptococcus pyogenes.
Ardanuy C; Tubau F; Liñares J; Domínguez MA; Pallarés R; Martín R;
Antimicrob Agents Chemother; 2005 Feb; 49(2):827-9. PubMed ID: 15673780
[TBL] [Abstract][Full Text] [Related]
6. A rapid increase in macrolide resistance in Streptococcus pyogenes isolated in Poland during 1996-2002.
Szczypa K; Sadowy E; Izdebski R; Hryniewicz W
J Antimicrob Chemother; 2004 Oct; 54(4):828-31. PubMed ID: 15329367
[TBL] [Abstract][Full Text] [Related]
7. Decrease in macrolide resistance and clonal instability among Streptococcus pyogenes in Portugal.
Silva-Costa C; Pinto FR; Ramirez M; Melo-Cristino J;
Clin Microbiol Infect; 2008 Dec; 14(12):1152-9. PubMed ID: 19046174
[TBL] [Abstract][Full Text] [Related]
8. Low macrolide resistance in Streptococcus pyogenes in Southern Argentina.
Rubinstein G; Amoroso AM; Bavdaz B; De Bunder S; Blazquez N; Gutkind GO
Int J Antimicrob Agents; 2005 May; 25(5):450-2. PubMed ID: 15848305
[No Abstract] [Full Text] [Related]
9. Plasmid-Borne erm(T) from invasive, macrolide-resistant Streptococcus pyogenes strains.
Woodbury RL; Klammer KA; Xiong Y; Bailiff T; Glennen A; Bartkus JM; Lynfield R; Van Beneden C; Beall BW;
Antimicrob Agents Chemother; 2008 Mar; 52(3):1140-3. PubMed ID: 18180360
[TBL] [Abstract][Full Text] [Related]
10. Multicentre surveillance of the prevalence and molecular epidemiology of macrolide resistance among pharyngeal isolates of group A streptococci in the USA.
Green MD; Beall B; Marcon MJ; Allen CH; Bradley JS; Dashefsky B; Gilsdorf JR; Schutze GE; Smith C; Walter EB; Martin JM; Edwards KM; Barbadora KA; Wald ER
J Antimicrob Chemother; 2006 Jun; 57(6):1240-3. PubMed ID: 16556634
[TBL] [Abstract][Full Text] [Related]
11. Erythromycin-resistant group A streptococci.
Shulman ST; Tanz R; Kabat W
N Engl J Med; 2002 Aug; 347(8):614-5; author reply 614-5. PubMed ID: 12195586
[No Abstract] [Full Text] [Related]
12. Macrolide-resistant Streptococcus pyogenes in the United States, 2002-2003.
Richter SS; Heilmann KP; Beekmann SE; Miller NJ; Miller AL; Rice CL; Doern CD; Reid SD; Doern GV
Clin Infect Dis; 2005 Sep; 41(5):599-608. PubMed ID: 16080080
[TBL] [Abstract][Full Text] [Related]
13. [Emergence of macrolide resistant Streptococcus pyogenes strains in pediatric patients in France].
Mariani-Kurkdjian P; Doit C; Deforche D; Brahimi N; Francois M; Van den Abbeele T; Bingen E
Pathol Biol (Paris); 2004 Oct; 52(8):489-92. PubMed ID: 15465270
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and molecular mechanism of macrolide resistance in beta-haemolytic streptococci in The Netherlands.
Buter CC; Mouton JW; Klaassen CH; Handgraaf CM; Sunnen S; Melchers WJ; Sturm PD
Int J Antimicrob Agents; 2010 Jun; 35(6):590-2. PubMed ID: 20353884
[TBL] [Abstract][Full Text] [Related]
15. Declining macrolide resistance in Streptococcus pyogenes in Portugal (2007-13) was accompanied by continuous clonal changes.
Silva-Costa C; Ramirez M; Melo-Cristino J;
J Antimicrob Chemother; 2015 Oct; 70(10):2729-33. PubMed ID: 26142474
[TBL] [Abstract][Full Text] [Related]
16. Effect of macrolide consumption on erythromycin resistance in Streptococcus pyogenes in Finland in 1997-2001.
Bergman M; Huikko S; Pihlajamäki M; Laippala P; Palva E; Huovinen P; Seppälä H;
Clin Infect Dis; 2004 May; 38(9):1251-6. PubMed ID: 15127336
[TBL] [Abstract][Full Text] [Related]
17. [Susceptibility of Streptococcus pyogenes to macrolides and quinolones in Guadalajara, Spain].
Rodríguez-Zurita ME; Solís del Baño S; Robres Guillén P; González Praetorius A; Gimeno Fernández C; Pérez Pomata MT; Bisquert Santiago J
Rev Esp Quimioter; 2003 Mar; 16(1):61-4. PubMed ID: 12750759
[TBL] [Abstract][Full Text] [Related]
18. Antimicrobial susceptibility and macrolide resistance genes in Streptococcus pyogenes collected in Austria and Hungary.
Gattringer R; Sauermann R; Lagler H; Stich K; Buxbaum A; Graninger W; Georgopoulos A
Int J Antimicrob Agents; 2004 Sep; 24(3):290-3. PubMed ID: 15325435
[TBL] [Abstract][Full Text] [Related]
19. Decline in macrolide-resistant Streptococcus pyogenes isolates from French children.
d'Humières C; Cohen R; Levy C; Bidet P; Thollot F; Wollner A; Bingen E
Int J Med Microbiol; 2012 Dec; 302(7-8):300-3. PubMed ID: 23103047
[TBL] [Abstract][Full Text] [Related]
20. Clonal diversity among erythromycin-resistant beta-haemolytic Streptococcus isolates in La Rioja, Spain.
Portillo A; Gastañares MJ; Ruiz-Larrea F; Torres C
J Antimicrob Chemother; 2003 Sep; 52(3):485-8. PubMed ID: 12888595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
